The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Risks for Incident Human Papillomavirus Infection and Low-Grade Squamous Intraepithelial Lesion Development in Young Females
Abstract
CONTEXT: Low-grade squamous intraepithelial lesions (LSILs) have been described as a benign cytological consequence of active human papillomavirus (HPV) replication. Several studies have reported that certain behavioral and biological risks exist for LSIL, suggesting that HPV alone is not sufficient for the development of LSIL. However, because most of these studies have been cross-sectional, it is not known whether behavioral and biological risks are simply risks for HPV infection itself. OBJECTIVE: To prospectively examine risks of incident HPV infection in HPV-negative females and of incident LSIL development in females with HPV infection. DESIGN: Prospective cohort study conducted between 1990-2000, with a median follow-up of 50 months. SETTING AND PARTICIPANTS: Females aged 13 to 21 years who attended 2 family planning clinics in the San Francisco bay area; 496 had prevalent HPV infection and 105 were HPV-negative. MAIN OUTCOME MEASURE: Incident development of HPV infection and LSIL, analyzed by various demographic, behavioral, and clinical risk factors. RESULTS: Fifty-four incident HPV infections occurred in the 105 females who were HPV-negative at study entry (median duration of follow-up for those who remained HPV-negative was 26 months). Multivariable analysis showed that risks of HPV included sexual behavior (relative hazard [RH], 10.10; 95% confidence interval [CI], 3.24-31.50 per new partner per month), history of herpes simplex virus (RH, 3.54; 95% CI, 1.37-9.10), and history of vulvar warts (RH, 2.73; 95% CI, 1.27-5.87). Current use of oral contraceptives had a significantly protective effect (RH, 0.49; 95% CI, 0.28-0.86). Among the 496 individuals who were HPV-positive at baseline or in follow-up, there were 109 incident cases of LSIL during the follow-up interval, with a median follow-up time of 60 months for those who never developed LSIL. Human papillomavirus infection was the most significant risk factor for development of LSIL. The multivariable model showed the following risks for LSIL: HPV infection for less than 1 year (RH, 7.40; 95% CI, 4.74-11.57); HPV infection for 1 to 2 years (RH, 10.27; 95% CI, 5.64-18.69); HPV infection for 2 to 3 years (RH, 6.11; 95% CI, 1.86-20.06); and daily cigarette smoking (RH, 1.67; 95% CI, 1.12-2.48). CONCLUSION: Our results indicate distinct risks for HPV and LSIL. In addition, most women with HPV infection in our study did not develop LSIL within a median follow-up period of 60 months. These findings underscore the hypothesis that certain biological risks thought to be associated with LSIL are, in fact, risks for acquisition of HPV. Cigarette smoking was a risk specific to LSIL, supporting the role of tobacco in neoplastic development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Association of Human Papillomavirus Types 16 and 18 E6 Proteins with p53
Werness, B. A., Levine, A. J., & Howley, P. M. (1990) · Science · doi:10.1126/science.2157286 · Cited by 2,562
Natural History of Cervicovaginal Papillomavirus Infection in Young Women
Ho, G. Y. F., Bierman, R., Beardsley, L., Chang, C. J., & Burk, R. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199802123380703 · Cited by 2,329
NATURAL HISTORY OF CERVICOVAGINAL PAPILLOMAVIRUS INFECTION IN YOUNG WOMEN
Loria, G. R., Ierman, R. O. B., Eardsley, L. E. B., & Hang, H. J. C. (1998) · Cited by 1,890
E2F: a Link Between the Rb Tumor Suppressor Protein and Viral Oncoproteins
Nevins, J. R. (1992) · Science · doi:10.1126/science.1411535 · Cited by 1,506
Bauer, H. M. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03460040048027 · Cited by 952
Gravitt, P. E., Peyton, C. L., Apple, R. J., & Wheeler, C. M. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.10.3020-3027.1998 · Cited by 646
Moscicki, A.-B., Shiboski, S., Broering, J., Powell, K., Clayton, L., Jay, N., Darragh, T. M., Brescia, R., Kanowitz, S., Miller, S. B., et al. (1998) · The Journal of Pediatrics · doi:10.1016/s0022-3476(98)70445-7 · Cited by 564
Self-citationAshley, R. L., Militoni, J., Lee, F., Nahmias, A., & Corey, L. (1988) · Journal of Clinical Microbiology · doi:10.1128/jcm.26.4.662-667.1988 · Cited by 541
The Bethesda System for Reporting Cervical/Vaginal Cytologic Diagnoses
Kurman, R. J., & Solomon, D. (1995) · International Journal of Gynecological Pathology · doi:10.1097/00004347-199504000-00015 · Cited by 364
EFFECT OF CIGARETTE SMOKING ON CERVICAL EPITHELIAL IMMUNITY: A MECHANISM FOR NEOPLASTIC CHANGE?
Barton, S. E., Jenkins, D., Cuzick, J., Maddox, P. H., Edwards, R., & Singer, A. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90469-2 · Cited by 198
Tibbetts, T. A., Conneely, O. M., & O'Malley, B. W. (1999) · Biology of Reproduction · doi:10.1095/biolreprod60.5.1158 · Cited by 189
Nakagawa, M., Stites, D. P., Patel, S., Farhat, S., Scott, M., Hills, N. K., Palefsky, J. M., & Moscicki, A. (2000) · The Journal of Infectious Diseases · doi:10.1086/315706 · Cited by 175
Self-citationSyrjänen, K. J., Kataja, V. V., Yliskoski, M. H., Chang, F., Syrjänen, K. J., & Saarikoski, S. (1992) · PubMed · Cited by 152
Human Papillomavirus Infection Sexually Active Adolescent Females: Prevalence and Risk Factors
Moscicki, A., Palefsky, J. M., Gonzales, J., & Schoolnik, G. K. (1990) · Pediatric Research · doi:10.1203/00006450-199011000-00018 · Cited by 150
Self-citationTh1 Cytokine Patterns in Cervical Human Papillomavirus Infection
Scott, M. E., Stites, D. P., & Moscicki, A. (1999) · Clinical and Diagnostic Laboratory Immunology · doi:10.1128/cdli.6.5.751-755.1999 · Cited by 138
Self-citationDaling, J. R., Madeleine, M. M., McKnight, B., Carter, J. J., Wipf, G. C., Ashley, R. L., Schwartz, S. M., Beckmann, A. M., Hagensee, M. E., Mandelson, M. T., et al. (1996) · PubMed · Cited by 134
SCHIFFMAN, M. H., Haley, N. J., Felton, J. S., Andrews, A. W., Kaslow, R. A., Lancaster, W. D., Kurman, R. J., Brinton, L. A., Lannom, L., & Hoffmann, D. (1987) · PubMed · Cited by 115
Variability of Human Papillomavirus DNA Testing in a Longitudinal Cohort of Young Women
Moscicki, A., Palefsky, J. M., Smith, G. D., SIBOSHSKI, S., & Schoolnik, G. K. (1993) · Obstetrics and Gynecology · doi:10.1097/00006250-199310000-00021 · Cited by 109
Self-citationMoscicki, A., Winkler, B., Irwin, C. E., & Schachter, J. (1989) · The Journal of Pediatrics · doi:10.1016/s0022-3476(89)80863-7 · Cited by 99
Self-citationMolecular methods for the detection of human papillomavirus infection.
Lörincz, A. T. (1996) · PubMed · Cited by 75
Biologic course of cervical human papillomavirus infection
Nash, J., Burke, T., & Hoskins, W. (1987) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(87)90078-6 · Cited by 74
FURTHER COMMENTS ON CANCER OF THE UTERINE CERVIX, SMOKING, AND HERPESVIRUS INFECTION
Winkelstein, W., Shillitoe, E. J., Brand, R., & Johnson, K. K. (1984) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113711 · Cited by 72
Ambros, R. A., & Kurman, R. J. (1990) · PubMed · Cited by 62
An evaluation of human papillomavirus testing as part of referral to colposcopy clinics
Cox, J., Schiffman, M., Winzelberg, A. J., & Patterson, J. (1993) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(93)90726-d · Cited by 52
Peripheral neuropathy associated with high-dose ara-C therapy
Borgeat, A., Stalder, M., & de Muralt, B. (1986) · Cancer · doi:10.1002/1097-0142(19860815)58:4<935::aid-cncr2820580422>3.0.co;2-o · Cited by 49
A MODEL FOR INTERVAL‐CENSORED TUBERCULOSIS OUTBREAK DATA
Smith, P. J., Thompson, T. J., & Jereb, J. (1997) · Statistics in Medicine · Cited by 22
Cited by
Human papillomavirus and cervical cancer
Schiffman, M., Castle, P. E., Jeronimo, J., Rodriguez, A. C., & Wacholder, S. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61416-0 · Cited by 2,985
Markowitz, L. E., Dunne, E. F., Saraiya, M., Lawson, H. W., Chesson, H., & Unger, E. R. (2007) · PsycEXTRA Dataset · doi:10.1037/e601292007-001 · Cited by 1,882
Bruni, L., Diaz, M., Castellsagué, X., Ferrer, E., Bosch, F. X., & de Sanjosé, S. (2010) · The Journal of Infectious Diseases · doi:10.1086/657321 · Cited by 1,641
A Controlled Trial of a Human Papillomavirus Type 16 Vaccine
Koutsky, L. A., Ault, K. A., Wheeler, C. M., Brown, D. R., Barr, E., Alvarez, F. B., Chiacchierini, L. M., & Jansen, K. U. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020586 · Cited by 1,602
Winer, R. L. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwf180 · Cited by 1,044
Metadata
- Authors
- Moscicki, A.-B.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2001-06-20
- Volume
- 285
- Issue
- 23
- Pages
- 2995
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2125223938
- Cited by
- 557
- References
- 26
- FWCI
- 20.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.